{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-24-000012","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2024-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.752932+00:00","generated_at":"2026-06-05T09:51:54.744228+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Cardinal Health elects Robert Azelby to Board of Directors, effective March 1, 2024","bullets":["Robert W. Azelby elected as an independent director, effective March 1, 2024.","Azelby brings over 30 years of biopharma, oncology, and specialty industry experience, including CEO roles.","He will serve on the Board's Risk Oversight Committee and receive standard non-employee director compensation.","Azelby currently serves on boards of ADC Therapeutics and Autolus Therapeutics; former CEO of Eliem Therapeutics and Alder BioPharmaceuticals."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-24-000012","json":"https://secwatch.observer/filing/0000721371-24-000012.json","markdown":"https://secwatch.observer/filing/0000721371-24-000012.md","text":"https://secwatch.observer/filing/0000721371-24-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137124000012/0000721371-24-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137124000012/cah-20240228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T09:51:54.744228+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e8d664adac","claim":"Robert W. Azelby was elected as Director at CARDINAL HEALTH INC.","evidence_excerpt":"On February 28, 2024, the Board of Directors (the “Board”) of Cardinal Health, Inc. (the “Company”) elected Robert W. Azelby to the Board, effective March 1, 2024, to serve until the 2024 annual meeting of shareholders and until his successor is elected and qualified or until his earlier resignation, removal from office, or death.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/721371/000072137124000012/0000721371-24-000012-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}